Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Tampa › NPI 1881632818
Hospital

ST. Joseph's Hospital, INC.

ST. Joseph's Hospital, INC. was paid $70.65M by Medicaid between Jan 2018 and Dec 2024, across 561 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoST. JOSEPH'S HOSPITAL, INC.
TAMPA, FL 33607
33aNPI1881632818assigned 06/03/2006
28Total paid$70.65M
24GClaims3,110,521
24DCodes billed561
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Florida

Rank by total paid#1 of 15
Median peer was paid$7.13M
This provider vs. median9.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GORKEN, LYNDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018238,868$2.65M
2019696,998$10.04M
2020580,637$8.08M
2021645,515$13.34M
2022574,716$18.64M
2023259,999$11.43M
2024incomplete113,788$6.48M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 158,449 145,502 $15.45M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 138,151 115,795 $10.76M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 54,233 43,563 $3.76M
80053 Comprehensive metabolic panel 4.3% 133,770 109,073 $3.02M
0202U Oncology (prostate), multianalyte, gene expression profiling 3.9% 39,686 37,971 $2.76M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.7% 14,919 12,674 $1.89M
70450 Computed tomography, head or brain; without contrast material 2.6% 24,119 19,079 $1.83M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.6% 22,708 21,474 $1.83M
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 2.4% 7,243 1,491 $1.72M
80048 Basic metabolic panel (calcium, ionized) 2.3% 71,730 49,739 $1.64M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 17,503 4,766 $1.40M
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1.6% 24,814 20,556 $1.15M
549 more codes
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.4% 13,048 $1.01M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1.3% 2,415 $917K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.3% 13,022 $889K
41899 Unlisted procedure, dentoalveolar structures 1.2% 2,251 $834K
G0378 Hospital observation service, per hour 1.2% 73,977 $826K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 19,583 $823K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 4,683 $676K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 28,730 $665K
36415 Collection of venous blood by venipuncture <1% 203,957 $658K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 6,430 $655K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 8,034 $600K
81025 <1% 52,893 $592K
59899 <1% 2,866 $516K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 4,510 $487K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 9,509 $423K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,951 $412K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 2,109 $381K
70551 Magnetic resonance imaging, brain; without contrast material <1% 3,228 $372K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,884 $369K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 6,471 $347K
82948 <1% 66,970 $311K
87086 Culture, bacterial; quantitative colony count, urine <1% 44,483 $301K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,541 $294K
81003 <1% 86,073 $284K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,324 $281K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 7,898 $281K
90935 Hemodialysis procedure with single evaluation by a physician <1% 321 $266K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,947 $257K
44970 <1% 242 $241K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,734 $240K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 5,734 $237K
71046 Radiologic examination, chest; 2 views <1% 37,004 $235K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 20,122 $215K
96361 Intravenous infusion, hydration; each additional hour <1% 3,857 $213K
72125 Computed tomography, cervical spine; without contrast material <1% 7,515 $195K
87631 <1% 2,949 $184K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 8,046 $179K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,568 $166K
70498 <1% 1,061 $160K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 18,868 $159K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 201,131 $157K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 23,910 $156K
97162 <1% 2,594 $155K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 10,053 $154K
93017 <1% 3,034 $132K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 3,264 $123K
96415 <1% 2,939 $122K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 149 $120K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 223 $104K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 18,657 $101K
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) <1% 3,763 $99K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 14,573 $94K
84702 <1% 9,115 $93K
70491 <1% 600 $92K
96367 <1% 1,569 $91K
97161 <1% 2,253 $90K
84443 Thyroid stimulating hormone (TSH) <1% 31,680 $90K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,055 $82K
71045 Radiologic examination, chest; single view <1% 39,455 $81K
36430 <1% 1,632 $79K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,027 $76K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 61,535 $72K
75574 <1% 1,135 $71K
72131 <1% 1,563 $67K
87536 <1% 2,982 $66K
87070 <1% 4,207 $59K
73564 <1% 4,819 $56K
92526 <1% 2,694 $56K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 11,782 $55K
54161 <1% 250 $53K
73130 <1% 3,744 $50K
A9270 Non-covered item or service <1% 13,311 $49K
84484 <1% 46,796 $47K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 832 $46K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 44,811 $45K
73110 <1% 2,957 $45K
74018 <1% 5,882 $45K
74019 <1% 5,871 $45K
76377 <1% 680 $44K
73610 <1% 4,094 $44K
76825 <1% 764 $43K
73630 <1% 4,491 $43K
88304 <1% 1,976 $41K
93976 <1% 4,256 $41K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,959 $40K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 6,036 $39K
74230 <1% 455 $39K
0100U <1% 2,077 $38K
70486 <1% 1,844 $37K
97802 <1% 329 $37K
80076 <1% 7,758 $37K
82657 <1% 1,919 $36K
76770 <1% 2,114 $35K
93970 <1% 3,215 $35K
85610 <1% 24,417 $34K
10061 <1% 897 $34K
95782 <1% 75 $33K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 633 $32K
80061 Lipid panel <1% 27,177 $32K
73030 <1% 4,161 $32K
87641 <1% 4,676 $32K
01922 <1% 1,987 $31K
86003 <1% 3,206 $31K
J7050 Infusion, normal saline solution, 250 cc <1% 6,317 $30K
73140 <1% 1,020 $30K
95716 <1% 322 $30K
93971 <1% 2,419 $30K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 15,427 $30K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 3,574 $29K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,712 $29K
36591 <1% 2,512 $28K
C1769 Guide wire <1% 3,341 $28K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 11,948 $27K
49083 <1% 149 $26K
83880 <1% 12,420 $25K
86850 <1% 6,861 $25K
70250 <1% 395 $24K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,617 $24K
J1644 Injection, heparin sodium, per 1000 units <1% 8,407 $23K
82805 <1% 3,970 $23K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 194 $22K
92610 <1% 713 $22K
73080 <1% 2,127 $22K
83735 <1% 17,451 $22K
95816 <1% 699 $22K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 17,661 $22K
82728 <1% 8,090 $21K
87081 <1% 3,497 $21K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 26,974 $20K
47562 <1% 13 $20K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 123 $19K
76801 <1% 6,233 $19K
87480 <1% 6,888 $18K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 2,369 $18K
73590 <1% 2,157 $17K
88341 <1% 959 $17K
81001 <1% 22,117 $17K
70496 <1% 1,004 $16K
73090 <1% 2,434 $16K
83516 <1% 2,003 $15K
80069 <1% 3,820 $15K
85660 <1% 1,588 $15K
J1815 Injection, insulin, per 5 units <1% 9,234 $15K
86140 <1% 17,002 $15K
96375 Therapeutic injection; each additional sequential IV push <1% 7,230 $14K
82274 <1% 1,093 $14K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,531 $14K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 775 $14K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 9,887 $14K
12001 <1% 1,631 $14K
89050 <1% 556 $13K
95819 <1% 596 $13K
88173 <1% 278 $13K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 11,786 $13K
95951 <1% 173 $13K
72100 <1% 4,333 $13K
83655 <1% 3,149 $13K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 531 $13K
86364 <1% 1,193 $13K
97165 <1% 352 $13K
J0690 Injection, cefazolin sodium, 500 mg <1% 6,011 $12K
86900 <1% 11,672 $12K
J2270 Injection, morphine sulfate, up to 10 mg <1% 17,031 $12K
87427 <1% 1,391 $12K
87077 <1% 12,815 $12K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,281 $12K
80074 <1% 1,569 $12K
85027 <1% 16,673 $12K
88342 <1% 1,871 $12K
81229 <1% 435 $12K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 28,284 $12K
85730 <1% 10,404 $12K
97597 <1% 464 $11K
12011 <1% 1,951 $11K
87186 <1% 10,579 $11K
J1756 Injection, iron sucrose, 1 mg <1% 880 $11K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,321 $11K
J1170 Injection, hydromorphone, up to 4 mg <1% 9,287 $11K
73560 <1% 859 $11K
85014 <1% 4,904 $11K
84703 <1% 6,941 $11K
76010 <1% 223 $11K
P9045 Infusion, albumin (human), 5%, 250 ml <1% 685 $11K
83036 Hemoglobin; glycosylated (A1C) <1% 18,603 $11K
12002 <1% 1,007 $10K
83690 <1% 27,080 $10K
83970 <1% 2,265 $10K
77076 <1% 334 $10K
J3490 Unclassified drugs <1% 1,387 $10K
49465 <1% 359 $10K
86901 <1% 11,671 $10K
92588 <1% 96 $10K
73502 <1% 1,954 $10K
86008 <1% 928 $9K
76870 <1% 793 $9K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 357 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,100 $9K
87040 <1% 8,348 $9K
J1650 Injection, enoxaparin sodium, 10 mg <1% 7,524 $9K
73070 <1% 73 $8K
29125 <1% 2,119 $8K
84145 <1% 6,062 $8K
87640 <1% 1,927 $8K
86923 <1% 2,212 $8K
71101 <1% 936 $7K
85380 <1% 5,867 $7K
76830 Ultrasound, transvaginal <1% 3,905 $7K
70360 <1% 871 $7K
86359 <1% 3,124 $7K
82247 <1% 1,481 $7K
85018 <1% 3,511 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 12,577 $7K
82330 <1% 3,077 $7K
86480 <1% 1,690 $7K
83021 <1% 1,152 $6K
83993 <1% 820 $6K
78264 <1% 44 $6K
83605 <1% 5,218 $6K
73060 <1% 1,039 $6K
97163 <1% 72 $6K
82607 <1% 7,689 $6K
96409 <1% 694 $6K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 2,548 $6K
86780 <1% 1,436 $6K
82785 <1% 3,726 $6K
72072 <1% 1,559 $6K
84480 <1% 1,675 $6K
87506 <1% 463 $6K
82150 <1% 1,578 $5K
82378 <1% 1,049 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,986 $5K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 197 $5K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 199 $5K
84439 <1% 13,122 $5K
47563 <1% 12 $5K
85045 <1% 3,895 $5K
93880 <1% 925 $5K
87510 <1% 6,888 $5K
87340 <1% 2,271 $5K
72170 <1% 1,381 $5K
72040 <1% 1,106 $5K
87660 <1% 6,947 $5K
29515 <1% 1,047 $5K
L4350 Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf <1% 208 $5K
86038 <1% 1,635 $5K
97116 <1% 978 $5K
88312 <1% 3,678 $5K
83540 <1% 7,925 $5K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 233 $5K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,973 $5K
82670 <1% 297 $4K
71250 <1% 211 $4K
82784 <1% 3,229 $4K
82550 <1% 4,409 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 7,693 $4K
99151 <1% 837 $4K
73552 <1% 1,346 $4K
74022 <1% 944 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 49 $4K
85576 <1% 896 $4K
0240U <1% 580 $4K
29530 <1% 860 $4K
87493 <1% 789 $4K
86258 <1% 303 $4K
84481 <1% 1,443 $4K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,825 $3K
90715 <1% 3,367 $3K
80164 <1% 2,048 $3K
93356 <1% 1,228 $3K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 2,075 $3K
84156 <1% 2,001 $3K
82803 <1% 231 $3K
76376 <1% 1,312 $3K
84100 <1% 5,400 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 384 $3K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 712 $3K
82270 <1% 329 $3K
J2060 Injection, lorazepam, 2 mg <1% 6,400 $3K
88185 <1% 67 $3K
86665 <1% 639 $3K
84132 <1% 2,268 $3K
83550 <1% 4,751 $3K
97535 Self-care/home management training, each 15 minutes <1% 362 $3K
J2785 Injection, regadenoson, 0.1 mg <1% 1,861 $3K
86592 <1% 1,149 $3K
84403 <1% 1,253 $3K
00170 Anesthesia for intraoral procedures, including biopsy <1% 2,956 $3K
51798 <1% 868 $3K
78226 <1% 15 $3K
87205 <1% 4,544 $3K
86360 <1% 3,122 $3K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 6,548 $3K
99152 <1% 903 $3K
86356 <1% 3,119 $2K
85652 <1% 12,362 $2K
73523 <1% 263 $2K
82105 <1% 723 $2K
83615 <1% 2,989 $2K
84550 <1% 2,094 $2K
86308 <1% 1,052 $2K
C9113 Injection, pantoprazole sodium, per vial <1% 2,540 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,345 $2K
72128 <1% 371 $2K
87209 <1% 727 $2K
J1453 Injection, fosaprepitant, 1 mg <1% 17 $2K
82077 <1% 1,024 $2K
80197 <1% 150 $2K
84295 <1% 1,447 $2K
10060 <1% 133 $2K
86803 <1% 998 $2K
84153 <1% 1,280 $2K
87338 <1% 631 $2K
87075 <1% 1,870 $2K
73660 <1% 68 $2K
82140 <1% 1,717 $2K
84146 <1% 248 $2K
72050 <1% 339 $2K
86769 <1% 338 $2K
92579 <1% 31 $2K
J1953 Injection, levetiracetam, 10 mg <1% 1,104 $2K
73000 <1% 82 $2K
92523 <1% 14 $2K
12013 <1% 153 $2K
93458 <1% 21 $2K
82746 <1% 5,070 $2K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 14 $2K
96417 <1% 202 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 59 $2K
0399T <1% 480 $2K
87015 <1% 1,512 $1K
99153 Mod sedat endo service >5yrs <1% 1,546 $1K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 2,873 $1K
43762 <1% 149 $1K
97803 <1% 12 $1K
94770 <1% 102 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,224 $1K
87486 <1% 3,273 $1K
87581 <1% 3,274 $1K
84305 <1% 217 $1K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 129 $1K
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,088 $1K
J0692 Injection, cefepime hydrochloride, 500 mg <1% 1,049 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,001 $1K
86902 <1% 314 $1K
82248 <1% 2,257 $1K
82043 <1% 3,780 $1K
77001 <1% 119 $1K
83520 <1% 237 $1K
J1940 Injection, furosemide, up to 20 mg <1% 1,682 $1K
94660 <1% 24 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 1,162 $1K
92550 <1% 310 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 14,769 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 2,208 $1K
95700 <1% 579 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 2,355 $1K
92585 <1% 28 $1K
92587 <1% 26 $1K
74240 <1% 29 $991.45
29130 <1% 360 $968.62
J3370 Injection, vancomycin hcl, 500 mg <1% 1,314 $947.78
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 723 $908.90
59025 Fetal non-stress test <1% 12 $901.48
97166 <1% 34 $900.26
00731 <1% 2,752 $896.41
87045 <1% 1,380 $896.36
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 2,194 $894.90
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 1,250 $887.62
95715 <1% 37 $885.86
73700 <1% 24 $865.43
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 348 $842.59
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,262 $810.45
83519 <1% 330 $809.04
86160 <1% 348 $795.16
84436 <1% 2,506 $787.64
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 466 $776.08
95957 <1% 188 $747.31
J0561 Injection, penicillin g benzathine, 100,000 units <1% 523 $740.20
62270 <1% 94 $737.98
85245 <1% 31 $724.60
92611 <1% 329 $707.30
87102 <1% 214 $673.26
84144 <1% 113 $666.31
85347 <1% 498 $661.57
36416 <1% 130 $653.21
81243 <1% 227 $646.74
00635 <1% 67 $604.09
87328 <1% 1,433 $603.84
89051 <1% 19 $599.72
94760 <1% 51 $590.19
82375 <1% 819 $576.44
83050 <1% 816 $576.44
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 185 $575.09
J0461 Injection, atropine sulfate, 0.01 mg <1% 1,614 $546.27
73620 <1% 34 $546.26
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 40 $529.22
0042T <1% 75 $528.47
96376 <1% 1,462 $525.66
82947 <1% 358 $503.20
87400 <1% 189 $502.91
70210 <1% 66 $495.86
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml <1% 483 $486.76
87329 <1% 1,421 $482.52
83525 <1% 997 $476.80
81376 <1% 57 $472.87
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 529 $436.72
88313 <1% 555 $420.12
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 120 $415.62
82656 <1% 46 $412.17
82653 <1% 42 $411.13
72110 <1% 46 $405.22
82533 <1% 121 $362.07
82945 <1% 33 $359.29
86376 <1% 1,456 $331.90
86800 <1% 482 $302.71
93315 <1% 13 $302.60
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 299 $299.44
82570 <1% 2,438 $281.40
86431 <1% 959 $276.54
83001 <1% 360 $256.26
86200 <1% 46 $244.72
83013 <1% 17 $234.53
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $232.74
87430 <1% 442 $217.90
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 126 $215.27
83721 <1% 259 $208.79
83002 <1% 247 $202.11
82139 <1% 155 $201.64
82950 <1% 146 $190.38
0352U <1% 139 $180.92
86255 <1% 1,812 $178.56
73600 <1% 35 $175.18
69200 <1% 53 $166.44
87481 <1% 319 $160.58
86762 <1% 73 $159.22
86706 <1% 254 $158.13
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 16 $157.14
00813 <1% 1,147 $154.99
84466 <1% 14 $149.44
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 19 $142.13
83020 <1% 1,153 $139.32
84402 <1% 373 $138.87
88108 <1% 400 $137.11
87449 <1% 1,467 $126.38
90686 <1% 1,153 $125.53
76937 <1% 118 $123.05
84165 <1% 151 $119.27
73562 <1% 194 $116.08
86039 <1% 304 $115.10
00811 <1% 301 $110.16
J3480 Injection, potassium chloride, per 2 meq <1% 860 $108.62
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 73 $107.60
87116 <1% 63 $100.09
00300 <1% 57 $96.34
86225 <1% 141 $92.93
82379 <1% 186 $90.74
85379 <1% 516 $86.66
87206 <1% 62 $86.17
86317 <1% 208 $83.56
82652 <1% 204 $72.52
85240 <1% 93 $71.50
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 106 $67.96
82565 <1% 85 $66.92
86709 <1% 243 $64.69
J8540 Dexamethasone, oral, 0.25 mg <1% 1,264 $52.99
87046 <1% 1,382 $52.51
86235 <1% 42 $50.37
85384 <1% 72 $49.74
88184 <1% 69 $48.87
G0008 Administration of influenza virus vaccine <1% 371 $47.11
69210 <1% 67 $46.61
86663 <1% 618 $43.10
82977 <1% 1,062 $40.30
82010 <1% 381 $38.19
86256 <1% 670 $38.18
00320 <1% 14 $37.59
84479 <1% 193 $32.38
86664 <1% 618 $27.33
84134 <1% 25 $26.39
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 949 $26.05
J3360 Injection, diazepam, up to 5 mg <1% 113 $25.11
87177 <1% 701 $24.80
29105 <1% 258 $24.58
00920 <1% 289 $22.46
80177 <1% 94 $20.46
88307 <1% 32 $15.19
81382 <1% 57 $13.95
82787 <1% 24 $13.70
86334 <1% 46 $10.47
86696 <1% 29 $9.91
J0456 Injection, azithromycin, 500 mg <1% 213 $8.78
J7510 Prednisolone oral, per 5 mg <1% 1,268 $7.99
00840 <1% 485 $7.29
85246 <1% 30 $6.85
86695 <1% 29 $6.60
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 208 $4.63
80178 <1% 14 $4.58
82103 <1% 33 $3.62
86231 <1% 34 $3.36
82705 <1% 28 $3.31
J1790 Injection, droperidol, up to 5 mg <1% 503 $2.14
00790 <1% 246 $2.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 133 $1.76
82465 <1% 125 $1.57
J9370 Vincristine sulfate, 1 mg <1% 343 $1.49
J7030 Infusion, normal saline solution , 1000 cc <1% 78 $1.24
51702 <1% 18 $1.18
88300 <1% 15 $0.87
C1758 Catheter, ureteral <1% 55 $0.31
84157 <1% 36 $0.29
87529 <1% 13 $0.29
94761 <1% 14 $0.29
83918 0% 32 $0.00
93567 0% 40 $0.00
86774 0% 12 $0.00
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) 0% 12 $0.00
00812 0% 13 $0.00
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml 0% 180 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 36 $0.00
24640 0% 53 $0.00
0353U 0% 314 $0.00
88230 0% 44 $0.00
00140 0% 36 $0.00
01920 0% 15 $0.00
92950 0% 15 $0.00
88262 0% 63 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 14 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 49 $0.00
90791 Psychiatric diagnostic evaluation 0% 219 $0.00
93568 0% 15 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 17 $0.00
73100 0% 13 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 30 $0.00
90670 0% 14 $0.00
J9260 Injection, methotrexate sodium, 50 mg 0% 38 $0.00
86922 0% 21 $0.00
88311 0% 17 $0.00
84210 0% 80 $0.00
83935 0% 40 $0.00
87425 0% 101 $0.00
00126 0% 26 $0.00
01400 0% 48 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 32 $0.00
J7999 Compounded drug, not otherwise classified 0% 36 $0.00
01480 0% 40 $0.00
96411 0% 51 $0.00
93531 0% 70 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 20 $0.00
G0009 Administration of pneumococcal vaccine 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGORKEN, LYNDA (VP, PATIENT FINANCIAL SERVICES)
Same official

Other billing entities under GORKEN, LYNDA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.